MetLife announced that its board of directors has approved a new $3 billion authorization for the company to repurchase its common stock. The new authorization is incremental to the $202 million remaining under the company’s prior authorization announced in May 2022. Commenting on the announcement, MetLife President and CEO Michel Khalaf said: "This new share repurchase authorization combined with the common stock dividend increase we announced in April reflects MetLife’s financial strength and balanced approach to capital management. Taken together, these actions reinforce our commitment to being a sound capital steward for our shareholders."
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MET:
